scholarly journals Clinical Experience and Dosimetry Outcome in Treating Breast Cancer with Field-in-Field Technique

2021 ◽  
Vol 10 (03) ◽  
pp. 35-43
Author(s):  
Bidyapati Jha ◽  
Hari Prasad Lamichhane ◽  
GisupNikha Prasiko ◽  
Raju Prasad Srivastava
Keyword(s):  
Breast Cancer ◽  
Clinical Experience ◽  
Field Technique

scholarly journals Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator

2019 ◽  
Vol 4 (4) ◽  
pp. 571-578 ◽  
Author(s):  
Andrew R. Barsky ◽  
Fionnbarr O'Grady ◽  
Christopher Kennedy ◽  
Neil K. Taunk ◽  
Lei Dong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Experience ◽  
Linear Accelerator ◽  
Flattening Filter Free ◽  
Flattening Filter ◽  
Initial Clinical Experience

scholarly journals Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

2021 ◽  
Author(s):  
Sarah S. Mougalian ◽  
Jonathan K. Kish ◽  
Jingchuan Zhang ◽  
Djibril Liassou ◽  
Bruce A. Feinberg
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Metastatic Breast Cancer ◽  
Clinical Experience ◽  
Real World ◽  
Metastatic Breast ◽  
The United States

Tangential Field Technique for Breast Cancer: The Dose to the Heart and Heart Subvolumes

2014 ◽  
Vol 90 (1) ◽  
pp. S221-S222 ◽  
Author(s):  
M. Duma ◽  
A. Herr ◽  
M. Oechsner ◽  
S. Kampfer ◽  
K. Trott ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Field Technique ◽  
Tangential Field

Single-photon emission computerized tomography with 99mTC-DARPIN9_29 in diagnostics of breast cancer with Her2/neu overexpression: first clinical experience

2021 ◽  
Vol 19 (1) ◽  
pp. 41-46
Author(s):  
Olga D. Bragina ◽  
Vladimir I. Chernov ◽  
Roman V. Zelchan ◽  
Anna A. Medvedeva ◽  
Evgeniy Yu. Garbukov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Computerized Tomography ◽  
Clinical Experience ◽  
Single Photon ◽  
Photon Emission ◽  
Single Photon Emission

Clinical potential of new antiestrogens.

1997 ◽  
Vol 15 (2) ◽  
pp. 840-852 ◽  
Author(s):  
W J Gradishar ◽  
V C Jordan
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Bone Density ◽  
Clinical Experience ◽  
Advanced Disease ◽  
Adjuvant Therapies ◽  
Laboratory Development ◽  
Medical Indications ◽  
Clinical Potential

PURPOSE Based on the data and clinical experience derived from tamoxifen usage, the properties of an ideal antiestrogen is described that could have applications as a breast cancer preventative agent, long-term adjuvant therdpy, or as a treatment for osteoporosis. Each of the new antiestrogens currently being tested is discussed in terms of laboratory development, toxicology, pharmacology, endocrinology, and clinical evaluation. And each new compound is assessed according to the properties of an ideal antiestrogen. METHODS A review of all published reports was facilitated by the use of Medline computer searches. RESULTS Numerous compounds are being evaluated in clinical trials and can be categorized as triphenylethylenes or tamoxifen analogs, pure antiestrogens, and targeted antiestrogens. Several of these compounds may have fewer uterotropic properties and greater effects on maintaining bone density compared with tamoxifen; however, the clinical experience (ie, patient-years of treatment) with any of these compounds is minimal. CONCLUSION Although many of these compounds appear promising, further evaluation will be necessary to determine the role these compounds may serve as preventive agents, adjuvant therapies, treatments for advanced disease, or other medical indications such as osteoporosis.

Sign in / Sign up

Export Citation Format

Share Document